Soy protein extract (SPE) exhibits differential in vitro cell proliferation effects in oral cancer and normal cell lines

Journal of Dietary Supplements

Volumn 8, Issue 2, 2011, Pages 169-188

  Kingsley, Karl ^a   Truong, Khanh ^a   Low, Erik ^a   Hill, Charles K ^a   Chokshi, Shruti B ^a   Phipps, Don ^a,b   West, M Abigail ^c   Keiserman, Mark A ^d   Bergman, Christine J ^a  

^a UNIVERSITY OF NEVADA   (United States)

^b BRIGHAM YOUNG UNIVERSITY   (United States)

^c Las Vegas Academy   (United States)

^d UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

Author keywords

apoptosis; in vitro; oral cancer; soy protein extract

Indexed keywords

ANTINEOPLASTIC AGENT; CASPASE 2; CASPASE 8; ISOFLAVONE DERIVATIVE; MESSENGER RNA; ORNITHINE DECARBOXYLASE; PLANT MEDICINAL PRODUCT; PROANTHOCYANIDIN; SOYBEAN PROTEIN;

ARTICLE; CELL CYCLE; CELL LINE; CELL PROLIFERATION; CHEMISTRY; COMPARATIVE STUDY; DIET THERAPY; DOSE RESPONSE; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; MOUTH TUMOR; PHYTOTHERAPY; PLANT SEED; SOYBEAN; SQUAMOUS CELL CARCINOMA; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; CARCINOMA, SQUAMOUS CELL; CASPASE 2; CASPASE 8; CELL CYCLE; CELL LINE; CELL LINE, TUMOR; CELL PROLIFERATION; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; ISOFLAVONES; MOUTH NEOPLASMS; ORNITHINE DECARBOXYLASE; PHYTOTHERAPY; PLANT PREPARATIONS; PROANTHOCYANIDINS; RNA, MESSENGER; SEEDS; SOYBEAN PROTEINS; SOYBEANS;

GLYCINE MAX;

EID: 79955801780     PISSN: 19390211     EISSN: 1939022X     Source Type: Journal    
DOI: 10.3109/19390211.2011.571656     Document Type: Article

References (75)

1. Adlercreutz H, Markkanen H and Watanabe S. Plasma concentrations of phyto-estrogens in Japanese men. Lancet, 1993; 342:1209-1210. (Pubitemid 23331713)
2. Anderson RL, Wolf WJ. Compositional changes in trypsin inhibitors, phytic acid, saponins and isoflavones related to soybean processing. J Nutr. 1995;125(3 Suppl):581S-588S.
3. Armstrong WB, Wan XS, Kennedy AR, Taylor TH, Meyskens FL Jr. Development of the Bowman-Birk inhibitor for oral cancer chemoprevention and analysis of Neu immunohistochemical staining intensity with Bowman-Birk inhibitor concentrate treatment. Laryngoscope 2003;113(10):1687-1702. (Pubitemid 37210969)
4. Bachran C, Heisler I, Bachran D, Dassler K, Ervens J, Melzig MF, Fuchs H. Chimeric toxins inhibit growth of primary oral squamous cell carcinoma cells. Cancer Biol Ther. 2008;7(2):237-242 [Epub 2007, Nov 3]. (Pubitemid 351590429)
5. Badger TM, RonisMJ, Simmen RC, Simmen FA. Soy protein isolate and protection against cancer. J Am Coll Nutr. 2005;24(2):146S-149S. (Pubitemid 40489661)
6. Bagchi M, Kuszynski CA, Balmoori J, Joshi SS, Stohs SJ, Bagchi D. Protective effects of antioxidants against smokeless tobacco-induced oxidative stress and modulation of bcl-2 and p53 genes in human oral keratinocytes. Free Rad Res. 2001;35:181-194. (Pubitemid 32734221)
7. Bernard-Gallon DJ, Satih S, Chalabi N, Rabiau N, Bosviel R, Fontana L, Bignon YJ. Phytoestrogens regulate the expression of genes involved in different biological processes in BRCA2 knocked downMCF-7,MDA-MB-231 andMCF-10a cell lines. OncolRep. 2010;23(3):647-653.
8. Blot WJ, McLaughlin JK,Winn DM, Austin DF, Greenberg RS, Preston-Martin S, Bernstein L, Schoenberg JB, Stemhagen A, Fraumeni JF Jr. Smoking and drinking in relation to oral and pharyngeal cancer. Cancer Res. 1998;489:3282-3287.
9. Browning AM, Walle UK, Walle T. Flavonoid glycosides inhibit oral cancer cell proliferation-role of cellular uptake and hydrolysis to the aglycones. J Pharm Pharmacol. 2005;57(8):1037-1042.
10. Bunnell A, Pettit N, Reddout N, Sharma K, O'Malley S, Chion M, Kingsley K. Analysis of primary risk factors for oral cancer from select US states with increasing rates. Tob Induc Dis. 2010;8:5.
11. Cederroth CR, Nef S. Soy, phytoestrogens and metabolism: a review. Mol Cell Endocrinol. 2009;304(1-2):30-42. Review [Epub 2009, Mar 9].
12. Chatelain K, Phippen S, McCabe J, Teeters CA, O'Malley S, Kingsley K. Cranberry and grape seed extracts inhibit the proliferative phenotype of oral squamous cell carcinomas. Evid Based Complement Alternat Med. 2008 [Epub ahead of print].
13. Craig WJ, Mangels AR; American Dietetic Association. Position of the American Dietetic Association: vegetarian diets. J Am Diet Assoc. 2009;109(7):1266-1282.
14. Cśaky I, Fekete S. Soybean: feed quality and safety. Part 1: biologically active components. A review. Acta Vet Hung. 2004;52(3):299-313. (Pubitemid 39092264)
15. Edwards BK, Howe HL, Ries LA, Thun MJ, Rosenberg HM, Yanick R,Wingo PA, Jemal A, Feigal EG. Annual report to the nation on the status of cancer, 1973-1999, featuring implications of age and aging on U.S. cancer burden. Cancer 2002;94:2766-2792. (Pubitemid 34478095)
16. Elattar TM, Virji AS. The inhibitory effect of curcumin, genistein, quercetin and cisplatin on the growth of oral cancer cells in vitro. Anticancer Res. 2000;20(3A):1733-1738. (Pubitemid 30628195)
17. Ferguson PJ, Kurowska E, Freeman DJ, Chambers AF, Koropatnick DJ. A flavonoid fraction from cranberry extract inhibits proliferation of human tumor cell lines. J Nutr. 2004;134(6):1529-1535. (Pubitemid 38720734)
18. Ferguson PJ, Kurowska EM, Freeman DJ, Chambers AF, Koropatnick J. In vivo inhibition of growth of human tumor cell lines by flavonoid fractions from cranberry extract. J Nutr Cancer 2006;56(1):86-94. (Pubitemid 46173418)
19. Friedman M, Brandon DL. Nutritional and health benefits of soy proteins. J Agric Food Chem. 2001;49(3):1069-1086. Review. (Pubitemid 32884913)
20. Furuya S, Takayama F, Mimaki Y, Sashida Y, Satoh K, Sakagami H. Cytotoxic activity of saponins from Camassia leichtlinii against human oral tumor cell lines. Anticancer Res. 2001;21(2A):959-964. (Pubitemid 32494193)
21. Gustin DM. Chemoprevention of head and neck cancer. Semin Oncol. 2004;31(6):769-777. (Pubitemid 39602682)
22. Hedlund TE,Maroni PD, Ferucci PG,DaytonR, Barnes S, JonesK,MooreR,Ogden LG,Whala K, Sackett HM, Gray KJ. Long-term dietary habits affect soy isoflavone metabolism and accumulation in prostatic fluid in Caucasian men. J Nutr. 2005;135:1400-1406. (Pubitemid 40799602)
23. Hedlund TE, van Bokhoven A, JohannesWU, Nordeen SK,Ogden LG. Prostatic fluid concentrations of isoflavonoids in soy consumers are sufficient to inhibit growth of benign and malignant prostatic epithelial cells in vitro. Prostate 2006;66:557-566.
24. Hsu A, Bray TM, Helferich WG, Doerge DR, Ho E. Differential effects of whole soy extract and soy isoflavones on apoptosis in prostate cancer cells. Exp Biol Med (Maywood). 2010;235(1):90-97.
25. Hsu S, Singh B, Schuster G. Induction of apoptosis in oral cancer cells: agents and mechanisms for potential therapy and prevention. Oral Oncol. 2004;40:461-473. (Pubitemid 38296830)
26. Huang ZR, Hung CF, Lin YK, Fang JY. In vitro and in vivo evaluation of topical delivery and potential dermal use of soy isoflavones genistein and daidzein. Int J Pharm. 2008;364(1):36-44 [Epub 2008, Aug 13].
27. Jane-Salas E, Chimenos-Kustner E, Lopez-Lopez J, Rosello-Llabres X. Importance of diet in the prevention of oral cancer. Med Oral. 2003;8:260-268.
28. Johnson TL, Lai MB, Lai JC, Bhushan A. Inhibition of cell proliferation and MAP kinase and Akt pathways in oral squamous cell carcinoma by genistein and biochanin A. Evid Based Complement Alternat Med. 2008 [Epub ahead of print].
29. Ju YH, Doerge DR, Woodling KA, Hartman JA, Kwak J, Helferich WG. Dietary genistein negates the inhibitory effect of letrozole on the growth of aromatase-expressing estrogen-dependent human breast cancer cells (MCF-7Ca) in vivo. Carcinogenesis 2008;29(11):2162-2168.
30. Kennedy AR. The evidence for soybean products as cancer preventive agents. J Nutr. 1995;125(3 Suppl):733S-743S.
31. Kim SH, Kim SH, Kim YB, Jeon YT, Lee SC, Song YS. Genistein inhibits cell growth by modulating various mitogen-activated protein kinases and AKT in cervical cancer cells. Ann N Y Acad Sci. 2009;1171:495-500.
32. King M, Chatelain K, Farris D, Jensen D, Pickup J, Swapp A, O'Malley S, Kingsley K. Oral squamous cell carcinoma proliferative phenotype is modulated by proanthocyanidins: a potential prevention and treatment alternative for oral cancer. BMC Complement Altern Med. 2007;7:22.
33. Kingsley K, Jensen D, Toponce R, Dye J, Martin D, Phippen S, Ross D, Halthore VS, O'Malley S. Inhibition of oral cancer growth in vitro is modulated through differential signaling pathways by over-the-counter proanthocyanidin supplements. J Diet SUPPL. 2010;7(2):130-144.
34. Kingsley K, O'Malley S, Chino M. Analysis of oral cancer epidemiology in the US reveals statespecific trends: implications for oral cancer prevention. BMC Public Health 2008;8(1):87.
35. Kobayashi H, Suzuki M, Kanayama N, Terao T. A soybean Kunitz trypsin inhibitor suppresses ovarian cancer cell invasion by blocking urokinase upregulation. Clin Exp Metastasis 2004;21(2):159-166. (Pubitemid 38988089)
36. Kreimer AR, Clifford GM, Boyle P, Franceschi S. Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiol Biomarkers Prev. 2005;14:467-475. (Pubitemid 40270113)
37. Kresty LA, Howell AB, Baird M. Cranberry proanthocyanidins induce apoptosis and inhibit acid-induced proliferation of human esophageal adenocarcinoma cells. J Agric Food Chem. 2008;56(3):676-680. (Pubitemid 351300230)
38. La Vecchia C, Franceschi S, Levi F. Epidemiological research on cancer with a focus on Europe. Eur J Cancer Prev. 2003;12:5-14. (Pubitemid 36233017)
39. MacDonald RS, Guo J, Copeland J, Browning JD Jr, Sleper D, Rottinghaus GE, Berhow MA. Environmental influences on isoflavones and saponins in soybeans and their role in colon cancer. J Nutr. 2005;135(5):1239-1242. (Pubitemid 40638335)
40. Matsukawa Y, Marui N, Sakai T, Satomi Y, Yoshida M, Matsumoto K, Nishino H, Aoike A. Genistein arrests cell cycle progression at G2-M. Cancer Res. 1993;53:1328-1331. (Pubitemid 23097111)
41. Messina M. Insights gained from 20 years of soy research. J Nutr. 2010;140(12):2289S-2295S [Epub 2010, Oct 27].
42. Messina M, McCaskill-StevensW, Lampe JW.Addressing the soy and breast cancer relationship: review, commentary, and workshop proceedings. J Natl Cancer Inst. 2006;98(18):1275-1284. (Pubitemid 44530723)
43. Messina MJ. Legumes and soybeans: overview of their nutritional profiles and health effects.Am J Clin Nutr. 1999;70(3 Suppl):439S-450S. (Pubitemid 29407122)
44. Messina MJ, Loprinzi CL. Soy for breast cancer survivors: a critical review of the literature. J Nutr. 2001;131(11 Suppl):3095S-3108S. (Pubitemid 33070787)
45. Messina MJ, Wood CE. Soy isoflavones, estrogen therapy, and breast cancer risk: analysis and commentary. Nutr J. 2008;3(7):17.
46. Miller CS, Johnstone BM. Human papillomavirus as a risk factor for oral squamous cell carcinoma: a meta-analysis, 1982-1997. Oral Surg Oral Med Oral Pathol. 2001;91:622-635. (Pubitemid 33601674)
47. Morton MS, Arisaka O, Miyake N, Morgan LD, Evans BA. Phytoestrogen concentrations in serum from Japanese men and women over forty years of age. J Nutr. 2002;132:3168-3171.
48. Park EJ, Pezzuto JM. Botanicals in cancer chemoprevention. Cancer Metastasis Rev. 2002;2:231-255. (Pubitemid 36071912)
49. Pavia M, Pileggi C, Nobile CGA, Angelillo IF. Association between fruit and vegetable consumption and oral cancer: a meta-analysis of observational studies. Am J Clin Nutr. 2006;83:1126-1134. (Pubitemid 44713114)
50. Perabo FG, Von Low EC, Ellinger J, von Rucker A, Muller SC, Bastian PJ. Soy isoflavone genistein in prevention and treatment of prostate cancer. Prostate Cancer Prostatic Dis. 2008;11:6-12. (Pubitemid 351250324)
51. Reddout N, Christensen T, Bunnell A, Jensen D, Johnson D, O'Malley S, Kingsley K. High risk HPV types 18 and 16 are potent modulators of oral squamous cell carcinoma phenotypes in vitro. Infect Agent Cancer 2007;2:21.
52. Ries LAG, Eisner MP, Kosary CL, Hankey BF, Miller BA, Clegg L, Mariotto A, Feuer EJ, Edwards BK (Eds.). SEER cancer statistics review, 1975-2002. Bethesda, MD: National Cancer Institute, 2005. Retrieved from http://seer.cancer.gov/csr/1975 2002/
53. Rodrigo KA, Rawal Y, Renner RJ, Schwartz SJ, Tian Q, Larsen PE, Mallery SR. Suppression of the tumorigenic phenotype in human oral squamous cell carcinoma cells by an ethanol extract derived from freeze-dried black raspberries. Nutr Cancer 2006;54:58-68. (Pubitemid 44141336)
54. Rosl FA, Arab A, Klevenz B, zur Hausen H. The effect of DNA methylation on gene regulation of human papillomaviruses. J Gen Virol. 1993;74:791-801. (Pubitemid 23154279)
55. Rothenberg SP. Increasing the dietary intake of folate: pros and cons. Semin Hematol. 1999;36:65-74. (Pubitemid 29048613)
56. Sacks FM, Lichtenstein A, Van Horn L, Harris W, Kris-Etherton P, Winston M; American Heart Association Nutrition Committee. Soy protein, isoflavones, and cardiovascular health: an American Heart Association Science Advisory for professionals from the Nutrition Committee. Circulation 2006;113(7):1034-1044. (Pubitemid 43879479)
57. Sakagami H, Jiang Y, Kusama K, Atsumi T, Ueha T, Toguchi M, Iwakura I, Satoh K, Fukai T, Nomura T. Induction of apoptosis by flavones, flavonols (3-hydroxyflavones) and isoprenoidsubstituted flavonoids in human oral tumor cell lines. Anticancer Res. 2000;20:271-277. (Pubitemid 30189765)
58. Shiboski CH, Shiboski SC, Silverman S Jr. Trends in oral cancer rates in the United States, 1973-1996. Community Dent Oral Epidemiol. 2000;28:249-256.
59. Shimazu T, Inoue M, Sasazuki S, IwasakiM, SawadaN,Yamaji T, Tsugane S; Japan Public Health Center-based Prospective Study Group. Isoflavone intake and risk of lung cancer: a prospective cohort study in Japan. Am J Clin Nutr. 2010;91(3):722-728 [Epub 2010, Jan 13].
60. Shirataki Y, Kawase M, Saito S, Hurihara T, Tanaka W, Satoh K, Sakagami H, Motohashi N. Selective cytotoxic activity of grape peel and seed extracts against oral tumor cell lines. Anticancer Res. 2000;20:423-426. (Pubitemid 30189789)
61. Singh-Gupta V, Zhang H, Yunker CK, Ahmad Z, Zwier D, Sarkar FH, Hillman GG. Daidzein effect on hormone refractory prostate cancer in vitro and in vivo compared to genistein and soy extract: potentiation of radiotherapy. Pharm Res. 2010;6:1115-1127.
62. Steiner C, Arnould S, Scalbert A, Manach C. Isoflavones and the prevention of breast and prostate cancer: new perspectives opened by nutrigenomics. Br J Nutr. 2008;99E(Suppl 1):ES78-ES108.
63. Stunkel W, Huang Z, Tan SH, O'Connor M, Bernard HU. Nuclear matrix attachment regions of human papillomavirus-16 repress or activate the E6 promoter depending on the physical state of the viral DNA. J Virol. 2000;74:2489-2501. (Pubitemid 30117558)
64. Susanto H, Fakhrudin N,Murti YB, Supriatno, SiswomiharjoW. Saponins from Plumeria acuminata Ait induce cell growth inhibition and apoptosis of oral squamous carcinoma cells. Chin J Dent Res. 2010;13(2):153-156.
65. Swain RA, St Clair L. The role of folic acid in deficiency states and prevention of disease. J Fam Pract. 1997;44:138-144. (Pubitemid 27087649)
66. Swango PA. Cancers of the oral cavity and pharynx in the United States: an epidemiologic overview. J Public Health Dent. 1996;56:309-318. (Pubitemid 126701498)
67. Taylor CK, Levy RM, Elliott JC, Burnett BP. The effect of genistein aglycone on cancer and cancer risk: a review of in vitro, preclinical, and clinical studies. Nutr Rev. 2009;67(7):398-415.
68. Terry P, Terry JB, Wolk A. Fruit and vegetable consumption in the prevention of cancer: an update. J Intern Med. 2001;250:280-290. (Pubitemid 32955614)
69. Thain A, Jenkins O, Clarke AR, Gaston K. CpG methylation directly inhibits binding of the human papillomavirus type 16 E2 protein to specificDNAsequences. JVirol. 1996;70:7233-7235. (Pubitemid 26307443)
70. Tsai CY, Chen YH, Chien YW, Huang WH, Lin SH. Effect of soy saponin on the growth of human colon cancer cells.World J Gastroenterol. 2010;16(27):3371-3376.
71. Wingo PA, Ries LA, Rosenberg HM, Miller DS, Edwards BK. Cancer incidence and mortality, 1973-1995: a report card for the US. Cancer 1998;82:1197-1207. (Pubitemid 28136536)
72. Xiao CW. Health effects of soy protein and isoflavones in humans. J Nutr. 2008;138(6):1244S-1249S. Review.
73. Xu B, Chang SK, Liu Z, Yuan S, Zou Y, Tan Y. Comparative studies on the chemical and cell-based antioxidant activities and antitumor cell proliferation properties of soy milk manufactured by conventional and commercial UHT methods. J Agric Food Chem. 2010;58(6):3558-3566.
74. Yan L, Spitznagel EL, Bosland MC. Soy consumption and colorectal cancer risk in humans: a meta-analysis. Cancer Epidemiol Biomarkers Prev. 2010;19(1):148-158.
75. Ye F,Wu J, Dunn T, Yi J, Tong X, Zhang D. The inhibition of cyclooxygenase-2 activity in head and neck cancer cells by genistein. Cancer Lett. 2004;211(1):39-46. (Pubitemid 38759767)